Vinod Labhasetwar - Publications

Affiliations: 
University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Pharmacology, Biomedical Engineering, Pharmaceutical Chemistry

155 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Vijayaraghavalu S, Gao Y, Rahman MT, Rozic R, Sharifi N, Midura RJ, Labhasetwar V. Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis. Biomaterials. 227: 119558. PMID 31654872 DOI: 10.1016/j.biomaterials.2019.119558  0.4
2019 Gao Y, Vijayaraghavalu S, Stees M, Kwon BK, Labhasetwar V. Evaluating accessibility of intravenously administered nanoparticles at the lesion site in rat and pig contusion models of spinal cord injury. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30930216 DOI: 10.1016/j.jconrel.2019.03.026  0.4
2018 Joshi CR, Raghavan V, Vijayaraghavalu S, Gao Y, Saraswathy M, Labhasetwar V, Ghorpade A. Reaching for the Stars in the Brain: Polymer-Mediated Gene Delivery to Human Astrocytes. Molecular Therapy. Nucleic Acids. 12: 645-657. PMID 30081235 DOI: 10.1016/j.omtn.2018.06.009  0.48
2018 Vijayaraghavalu S, Labhasetwar V. Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells. Drug Delivery and Translational Research. PMID 29947019 DOI: 10.1007/s13346-018-0556-y  0.4
2017 Kim MS, Stees M, Karuturi BV, Vijayaraghavalu S, Peterson RE, Madsen GL, Labhasetwar V. Pro-NP™ protect against TiO2 nanoparticle-induced phototoxicity in zebrafish model: exploring potential application for skin care. Drug Delivery and Translational Research. PMID 28299721 DOI: 10.1007/s13346-017-0374-7  0.4
2017 Joshi CR, Labhasetwar V, Ghorpade A. Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 28160121 DOI: 10.1007/s11481-016-9724-3  0.48
2016 Adjei IM, Sharma B, Peetla C, Labhasetwar V. Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27090164 DOI: 10.1016/j.jconrel.2016.04.019  1
2015 Petro M, Jaffer H, Yang J, Kabu S, Morris VB, Labhasetwar V. Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain. Biomaterials. 81: 169-180. PMID 26735970 DOI: 10.1016/j.biomaterials.2015.12.009  1
2015 Raghavan V, Vijayaraghavalu S, Peetla C, Yamada M, Morisada M, Labhasetwar V. Sustained Epigenetic Drug Delivery Depletes Cholesterol-Sphingomyelin Rafts from Resistant Breast Cancer Cells, Influencing Biophysical Characteristics of Membrane Lipids. Langmuir : the Acs Journal of Surfaces and Colloids. PMID 26439800 DOI: 10.1021/acs.langmuir.5b02601  1
2015 Kabu S, Gao Y, Kwon BK, Labhasetwar V. Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26343846 DOI: 10.1016/j.jconrel.2015.08.060  1
2015 Kabu S, Jaffer H, Petro M, Dudzinski D, Stewart D, Courtney A, Courtney M, Labhasetwar V. Blast-Associated Shock Waves Result in Increased Brain Vascular Leakage and Elevated ROS Levels in a Rat Model of Traumatic Brain Injury. Plos One. 10: e0127971. PMID 26024446 DOI: 10.1371/journal.pone.0127971  1
2015 Morris VB, Labhasetwar V. Arginine-rich polyplexes for gene delivery to neuronal cells. Biomaterials. 60: 151-60. PMID 26000961 DOI: 10.1016/j.biomaterials.2015.04.052  1
2015 Snow-Lisy DC, Sabanegh ES, Samplaski MK, Labhasetwar V. Anatomical Targeting Improves Delivery of Unconjugated Nanoparticles to the Testicle. The Journal of Urology. 194: 1155-61. PMID 25796115 DOI: 10.1016/j.juro.2015.03.076  1
2015 Labhasetwar V. The impact of 'negative data'. Drug Delivery and Translational Research. 5: 1-2. PMID 25787334 DOI: 10.1007/s13346-014-0212-0  1
2015 Cramer SA, Adjei IM, Labhasetwar V. Advancements in the delivery of epigenetic drugs. Expert Opinion On Drug Delivery. 12: 1501-12. PMID 25739728 DOI: 10.1517/17425247.2015.1021678  1
2014 Labhasetwar V. 10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002. Journal of Controlled Release : Official Journal of the Controlled Release Society. 190: 50-2. PMID 25356480  1
2014 Peetla C, Jin S, Weimer J, Elegbede A, Labhasetwar V. Biomechanics and thermodynamics of nanoparticle interactions with plasma and endosomal membrane lipids in cellular uptake and endosomal escape. Langmuir : the Acs Journal of Surfaces and Colloids. 30: 7522-32. PMID 24911361 DOI: 10.1021/la5015219  1
2014 Adjei IM, Sharma B, Labhasetwar V. Nanoparticles: cellular uptake and cytotoxicity. Advances in Experimental Medicine and Biology. 811: 73-91. PMID 24683028 DOI: 10.1007/978-94-017-8739-0_5  1
2014 Snow-Lisy DC, Sabanegh ES, Samplaski MK, Morris VB, Labhasetwar V. Superoxide dismutase-loaded biodegradable nanoparticles targeted with a follicle-stimulating hormone peptide protect Sertoli cells from oxidative stress. Fertility and Sterility. 101: 560-7. PMID 24289999 DOI: 10.1016/j.fertnstert.2013.10.034  1
2014 Adjei IM, Peetla C, Labhasetwar V. Heterogeneity in nanoparticles influences biodistribution and targeting. Nanomedicine (London, England). 9: 267-78. PMID 23799984 DOI: 10.2217/nnm.13.70  1
2014 Peppas NA, Duncan R, Wnek GE, Hoffman AS, Gao GH, Kim SW, Lee DS, Hadjiargyrou M, Touitou E, Ainbinder D, Mumper R, Rolland A, Niidome T, Labhasetwar V, Liu S, et al. Highly cited research articles in Journal of Controlled Release: Commentaries and perspectives by authors Journal of Controlled Release. 190: 29-74. DOI: 10.1016/S0168-3659(14)00482-9  1
2013 Brede C, Labhasetwar V. Applications of nanoparticles in the detection and treatment of kidney diseases. Advances in Chronic Kidney Disease. 20: 454-65. PMID 24206598 DOI: 10.1053/j.ackd.2013.07.006  1
2013 Singhal A, Morris VB, Labhasetwar V, Ghorpade A. Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress. Cell Death & Disease. 4: e903. PMID 24201802 DOI: 10.1038/cddis.2013.362  1
2013 Jaffer H, Adjei IM, Labhasetwar V. Optical imaging to map blood-brain barrier leakage. Scientific Reports. 3: 3117. PMID 24178124 DOI: 10.1038/srep03117  1
2013 Peetla C, Vijayaraghavalu S, Labhasetwar V. Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles. Advanced Drug Delivery Reviews. 65: 1686-98. PMID 24055719 DOI: 10.1016/j.addr.2013.09.004  1
2013 Lu S, Labhasetwar V. Drug Resistant Breast Cancer Cell Line Displays Cancer Stem Cell Phenotype and Responds Sensitively to Epigenetic Drug SAHA. Drug Delivery and Translational Research. 3: 183-94. PMID 23543868 DOI: 10.1007/s13346-012-0113-z  1
2013 Sharma B, Peetla C, Adjei IM, Labhasetwar V. Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy. Cancer Letters. 334: 228-36. PMID 23523612 DOI: 10.1016/j.canlet.2013.03.011  1
2013 Vijayaraghavalu S, Labhasetwar V. Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion. Cancer Letters. 331: 122-9. PMID 23305699 DOI: 10.1016/j.canlet.2012.12.009  1
2013 Vijayaraghavalu S, Dermawan JK, Cheriyath V, Labhasetwar V. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest. Molecular Pharmaceutics. 10: 337-52. PMID 23215027 DOI: 10.1021/mp3004622  1
2012 Vijayaraghavalu S, Peetla C, Lu S, Labhasetwar V. Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions. Molecular Pharmaceutics. 9: 2730-42. PMID 22817326 DOI: 10.1021/mp300281t  1
2012 Prabha S, Sharma B, Labhasetwar V. Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice. Cancer Gene Therapy. 19: 530-7. PMID 22595792 DOI: 10.1038/cgt.2012.26  1
2011 Snow-Lisy DC, Samplaski MK, Labhasetwar V, Sabanegh ES. Drug delivery to the testis: current status and potential pathways for the development of novel therapeutics. Drug Delivery and Translational Research. 1: 351-60. PMID 25788421 DOI: 10.1007/s13346-011-0039-x  1
2011 Labhasetwar V. Neurodegenerative diseases: challenges. Drug Delivery and Translational Research. 1: 349-50. PMID 25788420 DOI: 10.1007/s13346-011-0040-4  1
2011 Labhasetwar V, Egashira K, Hanes J. Editorial. Drug Delivery and Translational Research. 1: 1. PMID 25787886 DOI: 10.1007/s13346-010-0013-z  1
2011 Labhasetwar V. Drug resistance in cancer therapy. Drug Delivery and Translational Research. 1: 407-8. PMID 25786361 DOI: 10.1007/s13346-011-0047-x  1
2011 Sharma B, Ma W, Adjei IM, Panyam J, Dimitrijevic S, Labhasetwar V. Nanoparticle-mediated p53 gene therapy for tumor inhibition. Drug Delivery and Translational Research. 1: 43-52. PMID 22553503 DOI: 10.1007/s13346-010-0008-9  1
2011 Jaffer H, Morris VB, Stewart D, Labhasetwar V. Advances in stroke therapy. Drug Delivery and Translational Research. 1: 409-19. PMID 22201014 DOI: 10.1007/s13346-011-0046-y  1
2011 Foy SP, Labhasetwar V. Oh the irony: Iron as a cancer cause or cure? Biomaterials. 32: 9155-8. PMID 21963282 DOI: 10.1016/j.biomaterials.2011.09.047  1
2011 Borgmann K, Rao KS, Labhasetwar V, Ghorpade A. Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons. Aids Research and Human Retroviruses. 27: 853-62. PMID 21175357 DOI: 10.1089/AID.2010.0295  1
2011 Bhave R, Peetla C, Labhasetwar V. The effect of residual poly(vinylalcohol) on biophysical interaction of nanoparticles with endothelial cell model membrane International Journal of Nanoscience. 10: 539-545. DOI: 10.1142/S0219581X11009349  1
2010 Peetla C, Bhave R, Vijayaraghavalu S, Stine A, Kooijman E, Labhasetwar V. Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids. Molecular Pharmaceutics. 7: 2334-48. PMID 20958074 DOI: 10.1021/mp100308n  1
2010 Manthe RL, Foy SP, Krishnamurthy N, Sharma B, Labhasetwar V. Tumor ablation and nanotechnology. Molecular Pharmaceutics. 7: 1880-98. PMID 20866097 DOI: 10.1021/mp1001944  1
2010 Yallapu MM, Foy SP, Jain TK, Labhasetwar V. PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications. Pharmaceutical Research. 27: 2283-95. PMID 20845067 DOI: 10.1007/s11095-010-0260-1  1
2010 Foy SP, Manthe RL, Foy ST, Dimitrijevic S, Krishnamurthy N, Labhasetwar V. Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. Acs Nano. 4: 5217-24. PMID 20731413 DOI: 10.1021/nn101427t  1
2010 Vasir JK, Peetla C, Labhasetwar V. Strategies for intracellular delivery of polymer-based nanosystems Rsc Nanoscience and Nanotechnology. 98-113.  1
2009 Labhasetwar V, Zborowski M, Abramson AR, Basilion JP. Nanoparticles for imaging, diagnosis, and therapeutics. Molecular Pharmaceutics. 6: 1261-2. PMID 19799461 DOI: 10.1021/mp9001798  1
2009 Jain TK, Foy SP, Erokwu B, Dimitrijevic S, Flask CA, Labhasetwar V. Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials. 30: 6748-56. PMID 19765817 DOI: 10.1016/j.biomaterials.2009.08.042  1
2009 Rao KS, Ghorpade A, Labhasetwar V. Targeting anti-HIV drugs to the CNS. Expert Opinion On Drug Delivery. 6: 771-84. PMID 19566446 DOI: 10.1517/17425240903081705  1
2009 Peetla C, Stine A, Labhasetwar V. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Molecular Pharmaceutics. 6: 1264-76. PMID 19432455 DOI: 10.1021/mp9000662  1
2009 Jin S, Labhasetwar V. Nanotechnology in urology. The Urologic Clinics of North America. 36: 179-88, viii. PMID 19406319 DOI: 10.1016/j.ucl.2009.02.005  1
2009 Peetla C, Rao KS, Labhasetwar V. Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: study with TAT peptide-conjugated nanoparticles. Molecular Pharmaceutics. 6: 1311-20. PMID 19243206 DOI: 10.1021/mp900011h  1
2009 Peetla C, Labhasetwar V. Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake. Langmuir : the Acs Journal of Surfaces and Colloids. 25: 2369-77. PMID 19161268 DOI: 10.1021/la803361y  1
2009 Reddy MK, Labhasetwar V. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 1384-95. PMID 19124559 DOI: 10.1096/fj.08-116947  1
2008 Vasir JK, Labhasetwar V. Preparation of biodegradable nanoparticles and their use in transfection. Csh Protocols. 2008: pdb.prot4888. PMID 21356670 DOI: 10.1101/pdb.prot4888  1
2008 Reddy MK, Vasir JK, Sahoo SK, Jain TK, Yallapu MM, Labhasetwar V. Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured artery. Circulation. Cardiovascular Interventions. 1: 209-16. PMID 20031680 DOI: 10.1161/CIRCINTERVENTIONS.108.830018  1
2008 Rao KS, Reddy MK, Horning JL, Labhasetwar V. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials. 29: 4429-38. PMID 18760470 DOI: 10.1016/j.biomaterials.2008.08.004  1
2008 Vasir JK, Labhasetwar V. Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials. 29: 4244-52. PMID 18692238 DOI: 10.1016/j.biomaterials.2008.07.020  1
2008 Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, Vasir JK, Jain TK, Panda AK, Labhasetwar V. 3-D tumor model for in vitro evaluation of anticancer drugs. Molecular Pharmaceutics. 5: 849-62. PMID 18680382 DOI: 10.1021/mp800047v  1
2008 Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials. 29: 4012-21. PMID 18649936 DOI: 10.1016/j.biomaterials.2008.07.004  1
2008 Reddy MK, Wu L, Kou W, Ghorpade A, Labhasetwar V. Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress. Applied Biochemistry and Biotechnology. 151: 565-77. PMID 18509606 DOI: 10.1007/s12010-008-8232-1  1
2008 Peetla C, Labhasetwar V. Biophysical characterization of nanoparticle-endothelial model cell membrane interactions. Molecular Pharmaceutics. 5: 418-29. PMID 18271547 DOI: 10.1021/mp700140a  1
2008 Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Molecular Pharmaceutics. 5: 316-27. PMID 18217714 DOI: 10.1021/mp7001285  1
2008 Sahoo SK, Jain TK, Reddy MK, Labhasetwar V. Nano-sized carriers for drug delivery Nanobiotechnology: Bioinspired Devices and Materials of the Future. 329-348. DOI: 10.1007/978-1-59745-218-2_13  1
2008 Yallapu MM, Vasir JK, Jain TK, Vijayaraghavalu S, Labhasetwar V. Synthesis, characterization and antiproliferative activity of rapamycin-loaded poly(N-isopropylacrylamide)-based nanogels in vascular smooth muscle cells Journal of Biomedical Nanotechnology. 4: 16-24.  1
2007 Reddy MK, Vasir JK, Hegde GV, Joshi SS, Labhasetwar V. Erythropoietin induces excessive neointima formation: a study in a rat carotid artery model of vascular injury. Journal of Cardiovascular Pharmacology and Therapeutics. 12: 237-47. PMID 17875952 DOI: 10.1177/1074248406297326  1
2007 Vasir JK, Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Advanced Drug Delivery Reviews. 59: 718-28. PMID 17683826 DOI: 10.1016/j.addr.2007.06.003  1
2007 Vijayaraghavalu S, Raghavan D, Labhasetwar V. Nanoparticles for delivery of chemotherapeutic agents to tumors. Current Opinion in Investigational Drugs (London, England : 2000). 8: 477-84. PMID 17621878  1
2007 Labhasetwar V. A milestone in science: Discovery of the porosome - The universal secretory machinery in cells Journal of Biomedical Nanotechnology. 3. DOI: 10.1166/jbn.2007.023  1
2007 Braden A, Kashyap A, Vasir J, Labhasetwar V, Vishwanatha JK. Polymeric nanoparticles for sustained down-regulation of annexin A2 lead to reduction in proliferation and migration of prostate cancer cells Journal of Biomedical Nanotechnology. 3: 148-159. DOI: 10.1166/jbn.2007.010  1
2007 Vasir JK, Labhasetwar V. Controlling Cell Behavior via DNA and RNA Transfections Biomedical Nanostructures. 337-356. DOI: 10.1002/9780470185834.ch13  1
2007 Yallapu MM, Reddy MK, Labhasetwar V. Nanogels: Chemistry to Drug Delivery Biomedical Applications of Nanotechnology. 131-171. DOI: 10.1002/9780470152928.ch6  1
2007 Labhasetwar V, Leslie-Pelecky DL. Biomedical Applications of Nanotechnology Biomedical Applications of Nanotechnology. 1-249. DOI: 10.1002/9780470152928  1
2006 Vasir JK, Labhasetwar V. Polymeric nanoparticles for gene delivery. Expert Opinion On Drug Delivery. 3: 325-44. PMID 16640494 DOI: 10.1517/17425247.3.3.325  1
2006 Leslie-Pelecky DL, Labhasetwar V, Kraus RH. Nanobiomagnetics Advanced Magnetic Nanostructures. 461-490. DOI: 10.1007/0-387-23316-4_15  1
2005 Labhasetwar V. Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery. Current Opinion in Biotechnology. 16: 674-80. PMID 16263259 DOI: 10.1016/j.copbio.2005.10.009  1
2005 Sahoo SK, Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Molecular Pharmaceutics. 2: 373-83. PMID 16196490 DOI: 10.1021/mp050032z  1
2005 Vasir JK, Labhasetwar V. Targeted drug delivery in cancer therapy. Technology in Cancer Research & Treatment. 4: 363-74. PMID 16029056  1
2005 Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Molecular Pharmaceutics. 2: 194-205. PMID 15934780 DOI: 10.1021/mp0500014  1
2005 Sahoo SK, Panda AK, Labhasetwar V. Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells. Biomacromolecules. 6: 1132-9. PMID 15762686 DOI: 10.1021/bm0492632  1
2005 Rao KS, Panda AK, Labhasetwar V. Intravascular drug delivery systems and devices: Interactions at biointerface Surfaces and Interfaces For Biomaterials. 573-584. DOI: 10.1533/9781845690809.4.573  1
2005 Morales MA, Jain TK, Labhasetwar V, Leslie-Pelecky DL. Magnetic studies of iron oxide nanoparticles coated with oleic acid and Pluronic® block copolymer Journal of Applied Physics. 97. DOI: 10.1063/1.1850855  1
2004 Panyam J, Labhasetwar V. Targeting intracellular targets. Current Drug Delivery. 1: 235-47. PMID 16305387  1
2004 Prabha S, Labhasetwar V. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Molecular Pharmaceutics. 1: 211-9. PMID 15981924  1
2004 Panyam J, Labhasetwar V. Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Molecular Pharmaceutics. 1: 77-84. PMID 15832503  1
2004 Sahoo SK, Ma W, Labhasetwar V. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. International Journal of Cancer. 112: 335-40. PMID 15352049 DOI: 10.1002/ijc.20405  1
2004 Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. Journal of Pharmaceutical Sciences. 93: 1804-14. PMID 15176068 DOI: 10.1002/jps.20094  1
2004 Qaddoumi MG, Ueda H, Yang J, Davda J, Labhasetwar V, Lee VH. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharmaceutical Research. 21: 641-8. PMID 15139521 DOI: 10.1023/B:PHAM.0000022411.47059.76  1
2004 Ma W, Yu H, Wang Q, Jin H, Solheim J, Labhasetwar V. A novel approach for cancer immunotherapy: tumor cells with anchored superantigen SEA generate effective antitumor immunity. Journal of Clinical Immunology. 24: 294-301. PMID 15114060 DOI: 10.1023/B:JOCI.0000025451.41948.94  1
2004 Prabha S, Labhasetwar V. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharmaceutical Research. 21: 354-64. PMID 15032319 DOI: 10.1023/B:PHAM.0000016250.56402.99  1
2004 Satturwar PM, Fulzele SV, Panyam J, Mandaogade PM, Mundhada DR, Gogte BB, Labhasetwar V, Dorle AK. Evaluation of new rosin derivatives for pharmaceutical coating. International Journal of Pharmaceutics. 270: 27-36. PMID 14726119 DOI: 10.1016/j.ijpharm.2003.10.021  1
2003 Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discovery Today. 8: 1112-20. PMID 14678737 DOI: 10.1016/S1359-6446(03)02903-9  1
2003 Qaddoumi MG, Gukasyan HJ, Davda J, Labhasetwar V, Kim KJ, Lee VH. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis. Molecular Vision. 9: 559-68. PMID 14566223  1
2003 Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, Levy RJ, Labhasetwar V. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 92: 173-87. PMID 14499195 DOI: 10.1016/S0168-3659(03)00328-6  1
2003 Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. International Journal of Pharmaceutics. 262: 1-11. PMID 12927382 DOI: 10.1016/S0378-5173(03)00295-3  1
2003 Panyam J, Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharmaceutical Research. 20: 212-20. PMID 12636159 DOI: 10.1023/A:1022219003551  1
2003 Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Reviews. 55: 329-47. PMID 12628320 DOI: 10.1016/S0169-409X(02)00228-4  1
2002 Panyam J, Lof J, O'Leary E, Labhasetwar V. Efficiency of Dispatch and Infiltrator cardiac infusion catheters in arterial localization of nanoparticles in a porcine coronary model of restenosis. Journal of Drug Targeting. 10: 515-23. PMID 12575742 DOI: 10.1080/1061186021000038391  1
2002 Prabha S, Zhou WZ, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. International Journal of Pharmaceutics. 244: 105-15. PMID 12204570 DOI: 10.1016/S0378-5173(02)00315-0  1
2002 Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 1217-26. PMID 12153989 DOI: 10.1096/fj.02-0088com  1
2002 Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Journal of Controlled Release : Official Journal of the Controlled Release Society. 82: 105-14. PMID 12106981 DOI: 10.1016/S0168-3659(02)00127-X  1
2002 Koivu MK, Jääskeläinen SK, Falck BB. Multi-MUP analysis of laryngeal muscles. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 113: 1077-81. PMID 12088703 DOI: 10.1016/S1388-2457(02)00127-X  1
2002 Davda J, Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. International Journal of Pharmaceutics. 233: 51-9. PMID 11897410 DOI: 10.1016/S0378-5173(01)00923-1  1
2001 Raghuvanshi RJ, Mistra A, Talwar GP, Levy RJ, Labhasetwar V. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid. Journal of Microencapsulation. 18: 723-32. PMID 11695637 DOI: 10.1080/02652040110055261  1
2001 Davda J, Labhasetwar V. An update on angiogenesis therapy Critical Reviews in Eukaryotic Gene Expression. 11: 1-21. PMID 11693956  1
2000 Desai MP, Hilfinger JM, Amidon GL, Levy RJ, Labhasetwar V. Immune response with biodegradable nanospheres and alum: Studies in rabbits using staphylococcal enterotoxin B-toxoid Journal of Microencapsulation. 17: 215-225. PMID 10738697  1
2000 Zhou WZ, Labhasetwar V. Transfection of Caco-2 cells by PLGA-nanoparticles American Chemical Society, Polymer Preprints, Division of Polymer Chemistry. 41: 1635-1636.  1
1999 Labhasetwar V, Bonadio J, Goldstein SA, Levy RJ. Gene transfection using biodegradable nanospheres: Results in tissue culture and a rat osteotomy model Colloids and Surfaces B: Biointerfaces. 16: 281-290. DOI: 10.1016/S0927-7765(99)00079-X  1
1998 Labhasetwar V. A DNA controlled-release coating for gene transfer: Transfection in skeletal and cardiac muscle Journal of Pharmaceutical Sciences. 87: 1347-1350. PMID 9811488 DOI: 10.1021/js980077+  1
1998 Labhasetwar V, Song C, Humphrey W, Shebuski R, Levy RJ. Arterial uptake of biodegradable nanoparticles: Effect of surface modifications Journal of Pharmaceutical Sciences. 87: 1229-1234. PMID 9758682 DOI: 10.1021/js980021f  1
1998 Song C, Labhasetwar V, Cui X, Underwood T, Levy RJ. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: Results with an acute dog model Journal of Controlled Release. 54: 201-211. PMID 9724907 DOI: 10.1016/S0168-3659(98)00016-9  1
1998 Labhasetwar V, Strickberger SA, Underwood T, Davis J, Levy RJ. Prevention of acute inducible atrial flutter in dogs by using an ibutilide-polymer-coated pacing electrode Journal of Cardiovascular Pharmacology. 31: 449-455. PMID 9514191 DOI: 10.1097/00005344-199803000-00017  1
1998 Labhasetwar V, Chen W, Goldstein S, Bonadio J, Levy R. DNA coating for gene transfer Proceedings of the Controlled Release Society. 372-373.  1
1997 Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharmaceutical Research. 14: 1568-73. PMID 9434276 DOI: 10.1023/A:1012126301290  1
1997 Gottsauner-Wolf M, Jang Y, Lincoff AM, Cohen JL, Labhasetwar V, Poptic EJ, Forudi F, Guzman LA, DiCorleto PE, Levy RJ, Topol EJ, Ellis SG. Influence of local delivery of the protein tyrosine kinase receptor inhibitor tyrphostin-47 on smooth-muscle cell proliferation in a rat carotid balloon-injury model American Heart Journal. 133: 329-334. PMID 9060802  1
1997 Labhasetwar V, Chen B, Muller DWM, Bonadio J, Ciftci K, March K, Levy RJ. Gene-based therapies for restenosis Advanced Drug Delivery Reviews. 24: 109-120. DOI: 10.1016/S0169-409X(96)00485-1  1
1997 Humphrey WR, Erickson LA, Simmons CA, Northrup JL, Wishka DG, Morris J, Labhasetwar V, Song C, Levy RJ, Shebuski RJ. The effect of intramural delivery of polymeric nanoparticles loaded with the antiproliferative 2-aminochromone U-86983 on neointimal hyperplasia development in balloon-injured porcine coronary arteries Advanced Drug Delivery Reviews. 24: 87-108. DOI: 10.1016/S0169-409X(96)00484-X  1
1997 Labhasetwar V, Song C, Levy RJ. Nanoparticle drug delivery system for restenosis Advanced Drug Delivery Reviews. 24: 63-85. DOI: 10.1016/S0169-409X(96)00483-8  1
1997 Song CX, Labhasetwar V, Levy RJ. Controlled release of U-86983 from double-layer biodegradable matrices: Effect of additives on release mechanism and kinetics Journal of Controlled Release. 45: 177-192. DOI: 10.1016/S0168-3659(96)01551-9  1
1997 Song CX, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebuski RJ, Levy RJ. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery Journal of Controlled Release. 43: 197-212. DOI: 10.1016/S0168-3659(96)01484-8  1
1997 Levy RJ, Labhasetwar V, Underwood T, Song C, Chen W. Arterial nanoparticle administration for restenosis Proceedings of the Controlled Release Society. 189-190.  1
1997 Panek R, Chen W, Labhasetwar V, Hamby J, Levy R, Uprichard A, Keiser J. Prolonged vascular effects with drug loaded nanoparticles Proceedings of the Controlled Release Society. 819-820.  1
1997 Song C, Labhasetwar V, Levy R. Functional PCL/Polyether block copolymers as hemocompatible matrix for protein release Proceedings of the Controlled Release Society. 475-476.  1
1996 Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size Pharmaceutical Research. 13: 1838-1845. PMID 8987081 DOI: 10.1023/A:1016085108889  1
1996 Guzman LA, Labhasetwar V, Song C, Jang Y, Lincoff AM, Levy R, Topol EJ. Local intraluminal infusion of biodegradable polymeric nanoparticles: A novel approach for prolonged drug delivery after balloon angioplasty Circulation. 94: 1441-1448. PMID 8823004  1
1996 Levy RJ, Song CX, Labhasetwar V, Davis J, Underwood T. The effect of nanoparticle surface modification on arterial retention post angioplasty in a dog femoral artery model Proceedings of the Controlled Release Society. 393-394.  1
1996 Levy RJ, Labhasetwar V, Strickberger SA, Underwood T, Davis J. Controlled release implant dosage forms for cardiac arrhythmias: Review and perspectives Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents. 3: 137-142.  1
1996 Song CX, Labhasetwar V, Levy RJ. Modulation of release rates from double-layer poly (lactic-co-glycolic acid) films for periadventital implants in restenosis Proceedings of the Controlled Release Society. 473-474.  1
1996 Labhasetwar V, Underwood T, Davis J, Strickberger SA, Levy RJ. Controlled drug release pacing electrode system for prevention of postoperative atrial flutter Proceedings of the Controlled Release Society. 619-620.  1
1995 Villa AE, Guzman LA, Poptic EJ, Labhasetwar V, D'Souza S, Farrell CL, Plow EF, Levy RJ, DiCorleto PE, Topol EJ. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury Circulation Research. 76: 505-513. PMID 7895327  1
1995 Labhasetwar V, Underwood T, Schwendeman SP, Levy RJ. Iontophoresis for modulation of cardiac drug delivery in dogs Proceedings of the National Academy of Sciences of the United States of America. 92: 2612-2616. PMID 7708693 DOI: 10.1073/pnas.92.7.2612  1
1995 Labhasetwar V, Levy RJ. Novel Delivery of Antiarrhythmic Agents Clinical Pharmacokinetics. 29: 1-5. PMID 7586894 DOI: 10.2165/00003088-199529010-00001  0.32
1995 Schwendeman SP, Labhasetwar V, Levy RJ. Model features of a cardiac iontophoretic drug delivery implant Pharmaceutical Research. 12: 790-795. PMID 7479570  1
1995 Labhasetwar V, Mohan MS, Dorle AK. A study on zeta potential and dielectric constant of liposomes Journal of Microencapsulation. 12: 226. DOI: 10.3109/02652049509015293  1
1995 Levy RJ, Labhasetwar V, Song C, Lerner E, Chen W, Vyavahare N, Qu X. Polymeric drug delivery systems for treatment of cardiovascular calcification, arrhythmias and restenosis Journal of Controlled Release. 36: 137-147. DOI: 10.1016/0168-3659(95)00045-A  1
1995 Labhasetwar V, Song C, Humphrey W, Shebuski R, Levy RJ. Nanoparticles for site specific delivery of U-86983 in restenosis in pig coronary arteries Proceedings of the Controlled Release Society. 182-183.  1
1995 Song C, Labhasetwar V, Guzman L, Topol E, Levy RJ. Dexamethasone-nanoparticles for intra-arterial localization in restenosis in rats Proceedings of the Controlled Release Society. 444-445.  1
1994 Labhasetwar V, Underwood T, Gallagher M, Murphy G, Langberg J, Levy RJ. Sotalol controlled-release systems for arrhythmias: In vitro characterization, in vivo drug disposition, and electrophysiologic effects Journal of Pharmaceutical Sciences. 83: 156-164. PMID 8169781 DOI: 10.1002/jps.2600830209  1
1994 Choudhari KB, Labhasetwar V, Dorle AK. Liposomes as a carrier for oral administration of insulin: Effect of formulation factors Journal of Microencapsulation. 11: 319-325. PMID 8064555 DOI: 10.3109/02652049409040461  1
1994 Schwendeman SP, Amidon GL, Labhasetwar V, Levy RJ. Modulated drug release using iontophoresis through heterogeneous cation- exchange membranes. 2. Influence of cation-exchanger content on membrane resistance and characteristic times Journal of Pharmaceutical Sciences. 83: 1482-1494. PMID 7884674 DOI: 10.1002/jps.2600831023  1
1994 Labhasetwar V, Underwood T, Heil RW, Gallagher M, Langberg J, Levy RJ. Epicardial administration of ibutilide from polyurethane matrices: Effects on defibrillation threshold and electrophysiologic parameters Journal of Cardiovascular Pharmacology. 24: 826-840. PMID 7532762  1
1994 Labhasetwar V, Dorle AK. Dielectric constant during emulsification Drug Development and Industrial Pharmacy. 20: 2135-2141. DOI: 10.3109/03639049409050226  1
1994 Labhasetwar V, Underwood T, Levy RJ. Cardiac iontophoretic implant for antiarrhythmic agents Proceedings of the Controlled Release Society. 97-98.  1
1993 Labhasetwar V, Deshmukh SV, Dorle AK. Studies on some crystalline forms of ibuprofen Drug Development and Industrial Pharmacy. 19: 631-641. DOI: 10.3109/03639049309062971  1
1993 Labhasetwar V, Kadish A, Underwood T, Sirinek M, Levy RJ. The efficacy of controlled release D-sotalol-polyurethane epicardial implants for ventricular arrhythmias due to acute ischemia in dogs Journal of Controlled Release. 23: 75-85. DOI: 10.1016/0168-3659(93)90072-D  1
1993 Labhasetwar V, Schwendeman SW, Underwood T, Gallagher M, Nguyen T, Langberg J, Levy R. Epicardial iontophoretic delivery of antiarrhythmic agents Proceedings of the Controlled Release Society. 476-477.  1
1992 Levy RJ, Golomb G, Labhasetwar V. New frontiers in cardiovascular polymeric controlled release Polymeric Materials Science and Engineering, Proceedings of the Acs Division of Polymeric Materials Science and Engineering. 66.  1
1991 Labhasetwar V, Levy RJ. Implants for site-specific drug delivery Journal of Applied Biomaterials : An Official Journal of the Society For Biomaterials. 2: 211-212. PMID 10171143  1
1991 Labhasetwar VD, Dorle AK. A study on the zeta potential of microcapsules during ageing Journal of Microencapsulation. 8: 83-85. PMID 1880694 DOI: 10.3109/02652049109021861  1
1990 Labhasetwar VD, Puranik PK, Dorle AK. Study of shellac-glycerol esters as microencapsulating materials. II. Quantitative correlation between physico-chemical properties and release characteristics Journal of Microencapsulation. 7: 553-554. PMID 2266478 DOI: 10.3109/02652049009040478  1
1990 Labhasetwar VD, Dorle AK. Nanoparticles - a colloidal drug delivery system for primaquine and metronidazole Journal of Controlled Release. 12: 113-119. DOI: 10.1016/0168-3659(90)90087-A  1
1989 Labhasetwar VD, Puranik PK, Dorle AK. Study of shellac glycerol esters as microencapsulating materials Journal of Microencapsulation. 6: 115-118. PMID 2715911 DOI: 10.3109/02652048909019908  1
1988 Labhasetwar VD, Joshi SV, Dorle AK. A study on the dielectric constant of microcapsules during ageing Journal of Microencapsulation. 5: 339-341. PMID 3236154 DOI: 10.3109/02652048809036731  1
1988 Labhasetwar VD, Dorle AK. A study on the dielectric constant of salicylic acid and aspirin compacts during aging International Journal of Pharmaceutics. 47: 261-262. DOI: 10.1016/0378-5173(88)90239-6  1
1988 Labhasetwar VD, Puranik PK, Dorle AK. Study of shellac-glycerol esters as anhydrous binding agents in tablet formulations Indian Journal of Pharmaceutical Sciences. 50: 343-345.  1
1988 Narsimhan R, Labhasetwar VD, Lakhotia CL, Dorle AK. Timed-release noscapine microcapsules Indian Journal of Pharmaceutical Sciences. 50: 120-122.  1
Show low-probability matches.